Compliance, meet convenience – all in the Alto GxP Suite

The world’s most user-friendly SPR system can now support regulated workflows

Streamline development, enhance compliance

The features in the Alto GxP software expansion are specifically designed to support compliance with the FDA’s 21 CFR Part 11 guidelines.

Characterizing biomolecular interactions is essential throughout biologics discovery and development, and maintaining data integrity is critical at every step. The Alto Digital SPR system offers unmatched ease of use along with excellent precision and accuracy for binding kinetics measurements. 

The GxP Suite further enhances the platform with specialized software and qualification services that introduce audit-ready controls and enhanced traceability. With these capabilities, Alto can support compliant characterization from early screening through late-stage drug R&D.

Control Platform Access

The GxP software expansion offers robust data protection and integrity with user access controls, password policies, and edit-protected data formats and storage. The software expansion also supports up to three configurable signature levels and reasons. Once signed, results are locked to prevent further modifications.

Create Comprehensive Audit Trails

The GxP software expansion maintains detailed audit trails to ensure full traceability and compliance. Every modification to methods and result files is recorded with timestamps and user information. Audit trails also track system events, including logins, diagnostics, and calibration tests, providing a complete history to support data integrity and regulatory requirements.

Stay compliant with Alto

Learn how the GxP suite can support your regulated workflows